MedPath

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Phase 3
Completed
Conditions
Childhood Germ Cell Tumor
Extragonadal Germ Cell Tumor
Testicular Germ Cell Tumor
Registration Number
NCT00002596
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not known whether combining chemotherapy with bone marrow or peripheral stem cell transplantation is more effective than combination chemotherapy alone in treating men with germ cell tumors.

PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without bone marrow or peripheral stem cell transplantation in treating men with previously untreated germ cell tumors.

Detailed Description

OBJECTIVES:

* Compare the efficacy of bleomycin, etoposide, and cisplatin (BEP) with or without high-dose carboplatin, etoposide, and cyclophosphamide plus autologous bone marrow or peripheral blood stem cell transplantation in male patients with poor- or intermediate-risk germ cell tumors.

* Compare the toxicity of these regimens in these patients.

* Compare prospectively the prognosis in terms of the rate of decline of the serum tumor markers, human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP), in patients treated with these regimens.

* Correlate hCG and AFP with complete response and survival in patients treated with these regimens.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center and risk status (poor vs intermediate). Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive bleomycin IV on days 1, 8, and 15 and etoposide (VP-16) IV over 30-60 minutes and cisplatin (CDDP) IV over 30-60 minutes on days 1-5 (BEP). Filgrastim (G-CSF) is administered subcutaneously (SC) on days 7-16 or until blood counts recover. Treatment continues every 3 weeks for 4 courses in the absence of disease progression or unacceptable toxicity. G-CSF is discontinued 24 hours before initiating subsequent courses of chemotherapy, and withheld on days of bleomycin administration.

* Arm II: Patients receive 2 courses of BEP and G-CSF as in arm I. Patients who have no marrow involvement with tumor undergo harvest of autologous bone marrow before the first or second course of BEP. Patients who have bone marrow involvement with tumor undergo harvest of G-CSF-mobilized autologous peripheral blood stem cells (PBSC) on days 17-21 of the first and/or second courses of BEP. When blood counts recover, patients receive high-dose intensification comprising carboplatin IV over 1 hour, VP-16 IV over 30-60 minutes, and cyclophosphamide IV over 1 hour on days -5 to -3. Autologous bone marrow or PBSC are reinfused over 15-20 minutes on day 0. G-CSF is administered SC beginning 24 hours after transplantation and continuing until blood counts recover. Beginning 1-3 weeks after hospital discharge for the first transplantation and after recovery from any toxic effects, patients with a Karnofsky performance status of 70-100% receive a second course of high-dose intensification plus a second bone marrow or PBSC transplantation in the absence of disease progression or unacceptable toxicity.

Patients on both arms with brain metastases at presentation undergo radiotherapy and/or surgery concurrently with BEP, if medically indicated.

Patients with normal alpha fetoprotein (AFP) and human chorionic gonadotropin (hCG) tumor marker levels after completion of treatment on arm I or II undergo surgical resection of all residual masses. Patients who have no residual malignant tumor or undergo complete resection of only a mature teratoma receive no further therapy. Patients on arm I who undergo complete resection of residual malignant tumor receive 2 additional courses of VP-16 and CDDP without bleomycin. Patients on arm II who undergo complete resection of residual malignant tumor receive no additional chemotherapy. Patients with an unresectable residual malignant tumor receive additional therapy at the discretion of the treating physician. Patients with residual tumor marker (AFP and hCG) positivity after treatment on arm I or II undergo resection of residual masses if tumor marker values fall to normal by marker half-life.

PROJECTED ACCRUAL: A total of 270 patients (135 per treatment arm) will be accrued for this study within 4.4 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
270
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (153)

FirstHealth Moore Regional Hospital

🇺🇸

Pinehurst, North Carolina, United States

Arthur G. James Cancer Hospital - Ohio State University

🇺🇸

Columbus, Ohio, United States

Louis A. Weiss Memorial Hospital

🇺🇸

Chicago, Illinois, United States

Cleveland Clinic Taussig Cancer Center

🇺🇸

Cleveland, Ohio, United States

Veterans Affairs Medical Center - Las Vegas

🇺🇸

Las Vegas, Nevada, United States

Veterans Affairs Medical Center - San Diego

🇺🇸

San Diego, California, United States

MBCCOP - Hawaii

🇺🇸

Honolulu, Hawaii, United States

Veterans Affairs Medical Center - Fargo

🇺🇸

Fargo, North Dakota, United States

Cancer Research Center of Hawaii

🇺🇸

Honolulu, Hawaii, United States

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

Rebecca and John Moores UCSD Cancer Center

🇺🇸

La Jolla, California, United States

Walter Reed Army Medical Center

🇺🇸

Washington, District of Columbia, United States

Broward General Medical Center

🇺🇸

Fort Lauderdale, Florida, United States

Veterans Affairs Medical Center - Washington, DC

🇺🇸

Washington, District of Columbia, United States

Tuft-New England Medical Center

🇺🇸

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

Mercy Medical Center

🇺🇸

Des Moines, Iowa, United States

MBCCOP - LSU Health Sciences Center

🇺🇸

New Orleans, Louisiana, United States

James P. Wilmot Cancer Center

🇺🇸

Rochester, New York, United States

Iowa Methodist Medical Center

🇺🇸

Des Moines, Iowa, United States

Veterans Affairs Medical Center - Asheville

🇺🇸

Asheville, North Carolina, United States

Iowa Lutheran Hospital

🇺🇸

Des Moines, Iowa, United States

Veterans Affairs Medical Center - Buffalo

🇺🇸

Buffalo, New York, United States

Barnes-Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

Queens Cancer Center of Queens Hospital

🇺🇸

Jamaica, New York, United States

CCOP - Oklahoma

🇺🇸

Tulsa, Oklahoma, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

University of Massachusetts Memorial Medical Center - University Campus

🇺🇸

Worcester, Massachusetts, United States

Louisiana State University Health Sciences Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Veterans Affairs Medical Center - Columbia (Truman Memorial)

🇺🇸

Columbia, Missouri, United States

Veterans Affairs Medical Center - Baltimore

🇺🇸

Baltimore, Maryland, United States

Holden Comprehensive Cancer Center

🇺🇸

Iowa City, Iowa, United States

Veterans Affairs Medical Center - Syracuse

🇺🇸

Syracuse, New York, United States

Weill Medical College of Cornell University

🇺🇸

New York, New York, United States

Albert Einstein Clinical Cancer Center

🇺🇸

Bronx, New York, United States

Marlene and Stewart Greenebaum Cancer Center, University of Maryland

🇺🇸

Baltimore, Maryland, United States

Ireland Cancer Center

🇺🇸

Cleveland, Ohio, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Ellis Fischel Cancer Center - Columbia

🇺🇸

Columbia, Missouri, United States

CCOP - Metro-Minnesota

🇺🇸

Saint Louis Park, Minnesota, United States

Cape Fear Valley Health System

🇺🇸

Fayetteville, North Carolina, United States

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.

🇺🇸

Syracuse, New York, United States

Veterans Affairs Medical Center - Dallas

🇺🇸

Dallas, Texas, United States

Martha Jefferson Hospital

🇺🇸

Charlottesville, Virginia, United States

New Hanover Regional Medical Center

🇺🇸

Wilmington, North Carolina, United States

CCOP - Dayton

🇺🇸

Dayton, Ohio, United States

Virginia Oncology Associates - Norfolk

🇺🇸

Norfolk, Virginia, United States

NorthEast Oncology Associates

🇺🇸

Concord, North Carolina, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Veterans Affairs Medical Center - Amarillo

🇺🇸

Amarillo, Texas, United States

CCOP - Virginia Mason Research Center

🇺🇸

Seattle, Washington, United States

Fletcher Allen Health Care - University Health Center Campus

🇺🇸

Burlington, Vermont, United States

Puget Sound Oncology Consortium

🇺🇸

Seattle, Washington, United States

Brooke Army Medical Center

🇺🇸

Fort Sam Houston, Texas, United States

MBCCOP - Massey Cancer Center

🇺🇸

Richmond, Virginia, United States

CCOP - St. Vincent Hospital Cancer Center, Green Bay

🇺🇸

Green Bay, Wisconsin, United States

University of Wisconsin Comprehensive Cancer Center

🇺🇸

Madison, Wisconsin, United States

UCSF Comprehensive Cancer Center

🇺🇸

San Francisco, California, United States

Barbara Ann Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

University of Minnesota Cancer Center

🇺🇸

Minneapolis, Minnesota, United States

Veterans Affairs Medical Center - Minneapolis

🇺🇸

Minneapolis, Minnesota, United States

Veterans Affairs Medical Center - Durham

🇺🇸

Durham, North Carolina, United States

Duke Comprehensive Cancer Center

🇺🇸

Durham, North Carolina, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

Huntsman Cancer Institute

🇺🇸

Salt Lake City, Utah, United States

University of Colorado Cancer Center

🇺🇸

Denver, Colorado, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Oregon Cancer Institute

🇺🇸

Portland, Oregon, United States

CCOP - Columbia River Oncology Program

🇺🇸

Portland, Oregon, United States

St. Louis University Health Sciences Center

🇺🇸

Saint Louis, Missouri, United States

Elmhurst Hospital Center

🇺🇸

Elmhurst, New York, United States

CCOP - North Shore University Hospital

🇺🇸

Manhasset, New York, United States

Mount Sinai Medical Center, NY

🇺🇸

New York, New York, United States

State University of New York - Upstate Medical University

🇺🇸

Syracuse, New York, United States

Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center

🇺🇸

West Palm Beach, Florida, United States

Veterans Affairs Medical Center - Lakeside Chicago

🇺🇸

Chicago, Illinois, United States

Memorial Regional Hospital Comprehensive Cancer Center

🇺🇸

Hollywood, Florida, United States

Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

Saint Anthony Medical Center

🇺🇸

Rockford, Illinois, United States

West Suburban Center for Cancer Care

🇺🇸

River Forest, Illinois, United States

Veterans Affairs Medical Center - Chicago (Westside Hospital)

🇺🇸

Chicago, Illinois, United States

University of Chicago Cancer Research Center

🇺🇸

Chicago, Illinois, United States

Fort Wayne Medical Oncology and Hematology, Incorporated

🇺🇸

Fort Wayne, Indiana, United States

Indiana University Cancer Center

🇺🇸

Indianapolis, Indiana, United States

Veterans Affairs Medical Center - Indianapolis (Roudebush)

🇺🇸

Indianapolis, Indiana, United States

CCOP - Iowa Oncology Research Association

🇺🇸

Des Moines, Iowa, United States

Albert B. Chandler Medical Center, University of Kentucky

🇺🇸

Lexington, Kentucky, United States

MBCCOP - University of New Mexico HSC

🇺🇸

Albuquerque, New Mexico, United States

CCOP - Cedar Rapids Oncology Project

🇺🇸

Cedar Rapids, Iowa, United States

Lakeland Medical Center - St. Joseph

🇺🇸

Saint Joseph, Michigan, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Texas Tech University Health Science Center

🇺🇸

Lubbock, Texas, United States

Harrington Cancer Center

🇺🇸

Amarillo, Texas, United States

Veterans Affairs Medical Center - Madison

🇺🇸

Madison, Wisconsin, United States

CCOP - Marshfield Medical Research and Education Foundation

🇺🇸

Marshfield, Wisconsin, United States

Sutter Cancer Center

🇺🇸

Sacramento, California, United States

University of California Davis Cancer Center

🇺🇸

Sacramento, California, United States

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

CCOP - Southeast Cancer Control Consortium

🇺🇸

Winston-Salem, North Carolina, United States

Comprehensive Cancer Center at Wake Forest University

🇺🇸

Winston-Salem, North Carolina, United States

Ministry Medical Group - Northern Region

🇺🇸

Rhinelander, Wisconsin, United States

Robert H. Lurie Comprehensive Cancer Center, Northwestern University

🇺🇸

Chicago, Illinois, United States

North Shore University Hospital

🇺🇸

Manhasset, New York, United States

Northeast Alabama Regional Medical Center

🇺🇸

Anniston, Alabama, United States

Arizona Cancer Center

🇺🇸

Tucson, Arizona, United States

City of Hope Comprehensive Cancer Center

🇺🇸

Duarte, California, United States

Jonsson Comprehensive Cancer Center, UCLA

🇺🇸

Los Angeles, California, United States

USC/Norris Comprehensive Cancer Center and Hospital

🇺🇸

Los Angeles, California, United States

Sutter Health Western Division Cancer Research Group

🇺🇸

Greenbrae, California, United States

Chao Family Comprehensive Cancer Center

🇺🇸

Orange, California, United States

St. Joseph Hospital - Orange

🇺🇸

Orange, California, United States

John Muir Medical Center

🇺🇸

Walnut Creek, California, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

Veterans Affairs Medical Center - San Francisco

🇺🇸

San Francisco, California, United States

Lombardi Cancer Center

🇺🇸

Washington, District of Columbia, United States

CCOP - Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

Lenoir Memorial Hospital Cancer Center

🇺🇸

Kinston, North Carolina, United States

Abramson Cancer Center of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

CCOP - Geisinger Clinic and Medical Center

🇺🇸

Danville, Pennsylvania, United States

Lifespan: The Miriam Hospital

🇺🇸

Providence, Rhode Island, United States

University of Pittsburgh Cancer Institute

🇺🇸

Pittsburgh, Pennsylvania, United States

Vermont Cancer Center

🇺🇸

Burlington, Vermont, United States

Oncology and Hematology Associates of Southwest Virginia, Inc.

🇺🇸

Roanoke, Virginia, United States

Instituto de Enfermedades Neoplasicas

🇵🇪

Lima, Peru

Morristown Memorial Hospital

🇺🇸

Morristown, New Jersey, United States

CCOP - Southern Nevada Cancer Research Foundation

🇺🇸

Las Vegas, Nevada, United States

CCOP - Christiana Care Health Services

🇺🇸

Newark, Delaware, United States

Mountain States Tumor Institute

🇺🇸

Boise, Idaho, United States

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

Alegent Health-Midlands Community Hospital

🇺🇸

Papillion, Nebraska, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Norris Cotton Cancer Center

🇺🇸

Lebanon, New Hampshire, United States

San Juan City Hospital

🇵🇷

San Juan, Puerto Rico

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

CCOP - Northern New Jersey

🇺🇸

Hackensack, New Jersey, United States

Tulane University School of Medicine

🇺🇸

New Orleans, Louisiana, United States

Hackensack University Medical Center

🇺🇸

Hackensack, New Jersey, United States

Cooper University Hospital

🇺🇸

Camden, New Jersey, United States

University of Puerto Rico School of Medicine Medical Sciences Campus

🇵🇷

San Juan, Puerto Rico

University of Tennessee Cancer Institute

🇺🇸

Memphis, Tennessee, United States

CCOP - Sioux Community Cancer Consortium

🇺🇸

Sioux Falls, South Dakota, United States

Danville Radiation Therapy Center

🇺🇸

Memphis, Tennessee, United States

St. Mary's Medical Center

🇺🇸

Huntington, West Virginia, United States

Green Mountain Oncology Group

🇺🇸

Bennington, Vermont, United States

Veterans Affairs Medical Center - White River Junction

🇺🇸

White River Junction, Vermont, United States

Baptist Hospital East - Louisville

🇺🇸

Louisville, Kentucky, United States

Florida Hospital Cancer Institute

🇺🇸

Orlando, Florida, United States

Lineberger Comprehensive Cancer Center, UNC

🇺🇸

Chapel Hill, North Carolina, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath